Tag: Ligelizumab

CSU: Ligelizumab likely safe and effective for adolescents

Presented By
Prof. Bülent Şekerel, Hacettepe University, Turkey
Trial
Phase 2
Conference
EADV 2021
Type
Peer-reviewed article

18 November 2021 13:29

Ligelizumab for chronic spontaneous urticaria: a new star on the horizon

Presented By
Prof. Marcus Maurer, Charité Universitätsmedizin Berlin, Germany
Conference
EADV 2020
Type
Peer-reviewed article

17 December 2020 14:26

Ligelizumab for CSU: symptom control and high response rates in re-treatment

Presented By
Prof. Marcus Maurer, Charité – Universitätsmedizin Berlin, Germany
Conference
EADV 2019
Type
Peer-reviewed article

9 October 2019 14:45

Novel anti-IgE drug enables durable urticaria control

Presented By
Dr Diane Baker, Baker Allergy, Asthma, and Dermatology Clinic, USA
Conference
AAD 2019
Type
Peer-reviewed article

19 April 2019 20:22
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com